Treatment of Nonmetastatic Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of Nonmetastatic Breast Cancer

Published:2019-05-07 Issue:17 Volume:321 Page:1716
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Ruddy Kathryn J.¹,Ganz Patricia A.²³⁴

Affiliation:

1. Department of Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota

2. Department of Health Policy and Management, UCLA Fielding School of Public Health, Los Angeles, California

3. Department of Medicine, Division of Hematology Oncology, David Geffen School of Medicine, University of California, Los Angeles

4. Jonsson Comprehensive Cancer Center, University of California, Los Angeles

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

http:///jama/article-pdf/321/17/1716/17555668/jama_ruddy_2019_it_190006.pdf

Reference7 articles.

1. Breast cancer treatment: a review.;Waks;JAMA,2019

2. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.;Burstein;J Clin Oncol,2019

3. Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer.;Krop;J Clin Oncol,2017

4. Breast cancer, version 4.2017, NCCN Clinical Practice Guidelines in Oncology.;Gradishar;J Natl Compr Canc Netw,2018

5. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.;Runowicz;J Clin Oncol,2016

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence for breast cancer: Implications for diagnosis and management;Journal of Medicine, Surgery, and Public Health;2024-08

2. Experiences of women with breast cancer disclosing cancer-related cognitive impairment symptoms to health professionals: a Systematic review and meta-synthesis;Journal of Psychosocial Oncology;2024-04-22

3. D-mannose promotes the degradation of IDH2 through upregulation of RNF185 and suppresses breast cancer;Nutrition & Metabolism;2024-01-02

4. An “all-in-one” treatment and imaging nanoplatform for breast cancer with photothermal nanoparticles;Nanoscale Advances;2024

5. Resistance to Chemotherapy in Breast Cancer;Overcoming Breast Cancer Therapy Resistance;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3